Bertagnolli’s Push For Trial Reforms, Data Sharing Aligns With FDA

By Lia DeGroot, Beth Wang / May 23, 2023 at 6:05 PM
National Institutes of Health Director-nominee Monica Bertagnolli’s decades-long work to help reform the U.S. clinical trial enterprise, including in the cancer space, and enhance data-sharing across the research community likely will be a boon to the Biden administration, and especially FDA, according to HHS and advocates, as the agency works to increase diversity in clinical trials, streamline trial designs, break down currently existing data silos and meet the goals of the Cancer Moonshot program. Bertagnolli, who has served as director...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.